Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger nuclease-mediated genome editing is an advanced molecular tool that enables targeted modification of genomes through programmable recognition and cleavage at user-specified sites. It has paved the way for precise genetic engineering across many fields but faces competition from newer technologies due to challenges with design complexity and off-target risks. Nonetheless, it remains significant both as a foundational technology in genome engineering history and as an option where high specificity is required or alternative methods are less suitable.
Targeted DNA double-strand break induction via zinc finger-mediated DNA binding and FokI nuclease dimerization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc Finger Nuclease (ZFN) (ZFN).